Efficacy and Safety of Low-Dose Fluticasone Propionate Compared With Montelukast for Maintenance Treatment of Persistent Asthma
- 1 May 2002
- journal article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 77 (5) , 437-445
- https://doi.org/10.1016/s0025-6196(11)62212-x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Trends in the cost of illness for asthma in the United States, 1985-1994Journal of Allergy and Clinical Immunology, 2000
- Low-Dose Inhaled Corticosteroids and the Prevention of Death from AsthmaNew England Journal of Medicine, 2000
- Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthmaJournal of Allergy and Clinical Immunology, 2000
- Oral Montelukast, Inhaled Beclomethasone, and Placebo for Chronic AsthmaAnnals of Internal Medicine, 1999
- First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthmaThorax, 1998
- Should Antileukotriene Therapies Be Used Instead of Inhaled Corticosteroids in Asthma?American Journal of Respiratory and Critical Care Medicine, 1998
- Should Antileukotriene Therapies Be Used Instead of Inhaled Corticosteroids in Asthma?American Journal of Respiratory and Critical Care Medicine, 1998
- Montelukast, a Once-Daily Leukotriene Receptor Antagonist, in the Treatment of Chronic AsthmaA Multicenter, Randomized, Double-blind TrialArchives of internal medicine (1960), 1998
- Efficacy of Inhaled Fluticasone Propionate in Asthma Results from Topical and Not from Systemic ActivityAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter studyClinical Therapeutics, 1997